MyFinsight
Home
Blog
About
Contact
Sales and maturities
of investments
$25,505K
Proceeds from exercise of
stock options
$2,178K
Net cash provided by
investing activities
$25,505K
Net cash provided by
financing activities
$1,399K
Canceled cashflow
$779K
Increase (decrease) in
cash, cash...
$9,213K
Canceled cashflow
$17,691K
Stock-based compensation
$3,575K
Prepaid expenses and
other current assets
-$228K
Accounts payable
$219K
Depreciation and
amortization
$17K
Deferred taxes
$12K
Cash paid related to
withholding shares to...
$779K
Net cash used in
operating activities
-$17,691K
Canceled cashflow
$4,051K
Net loss
-$19,630K
Accrued expenses and
other current...
-$1,495K
Change in fair value of
derivative liability
$480K
Accretion of
available-for-sale investments,...
$106K
Lease liability, net
-$31K
Back
Back
Cash Flow
Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX)
source: myfinsight.com